renal pelvis/ureter urothelial carcinoma
renal pelvis/ureter urothelial carcinoma
Explore linked clinical trials. Standard reference: MONDO:002065436 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 / Phase 3 | 2026-10-08 | NCT04628767 | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, renal pelvis urothelial carcinoma, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Not stated | 2026-09-29 | NCT05874921 | |
| Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 3 | 2026-09-28 | NCT07498907 | |
| Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, kidney cancer, kidney disorder, neoplasm, renal pelvis/ureter urothelial carcinoma, urinary system disorder | Recruiting | Phase 2 | 2026-09-18 | NCT06948552 | |
| Screening for Urological Malignancies Using a Urine Exfoliated Cell Fluorescence Assay in a Hematuria Population | renal pelvis/ureter urothelial carcinoma | Recruiting | Not stated | 2026-09-10 | NCT07813260 | |
| A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma | Recruiting | Not applicable | 2026-09-10 | NCT06040762 | |
| Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC) | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Not stated | 2026-09-01 | NCT07793240 | |
| Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer | Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, carcinoma, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma | Recruiting | Not stated | 2026-08-10 | NCT07756437 | |
| OptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Not applicable | 2026-08-07 | NCT07751796 | |
| Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 | 2026-08-03 | NCT07741448 | |
| Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 / Phase 3 | 2026-08-03 | NCT06124976 | |
| ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study | renal pelvis/ureter urothelial carcinoma | Active, not recruiting | Phase 3 | 2026-07-30 | NCT04620239 | |
| Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 ) | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Phase 2 | 2026-07-22 | NCT07720921 | |
| Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 | 2026-07-16 | NCT05775471 | |
| Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Recruiting | Not applicable | 2026-07-10 | NCT07630155 | |
| Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, disease, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not stated | 2026-07-02 | NCT07614594 | |
| Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC) | renal pelvis/ureter urothelial carcinoma | Recruiting | Not applicable | 2026-06-25 | NCT07321210 | |
| Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Phase 2 | 2026-05-13 | NCT07584733 | |
| Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Not applicable | 2026-05-05 | NCT07557563 | |
| Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma | renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Not stated | 2026-04-24 | NCT07504939 | |
| Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma | Recruiting | Phase 1 | 2026-03-25 | NCT07492628 | |
| NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC | Disease Attributes, Disease Progression, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, renal pelvis/ureter urothelial carcinoma | Not yet recruiting | Phase 2 | 2026-02-17 | NCT07412171 | |
| Bladder EpiCheck European Haematuria Study | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematuria, Hemorrhage, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urination Disorders, Urogenital Diseases, bladder transitional cell carcinoma, renal pelvis/ureter urothelial carcinoma, urinary system disorder | Recruiting | Not stated | 2026-01-22 | NCT06818136 | |
| Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 | 2025-11-06 | NCT07225374 | |
| Ambulatory Flexible URS for UTUC Surveillance | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 1 | 2025-09-15 | NCT06848868 |